Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 301-306

  Milano, Michael T ^a   Chen, Yuhchyau ^a   Katz, Alan W ^a   Philip, Abraham ^a   Schell, Michael C ^a   Okunieff, Paul ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Oligometastases; Stereotactic body radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHITIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DERMATITIS; DISEASE COURSE; DYSPNEA; ESOPHAGITIS; FATIGUE; FEMALE; HEART MUSCLE ISCHEMIA; HEMOPTYSIS; HUMAN; KIDNEY CANCER; LOBAR PNEUMONIA; LUNG EMBOLISM; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT POSITIONING; PERICARDITIS; PNEUMOTHORAX; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TELANGIECTASIA; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DISEASE PROGRESSION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACIC NEOPLASMS; TREATMENT OUTCOME;

EID: 65649141282     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.03.005     Document Type: Article

References (34)

1. Timmerman R.D., Kavanagh B.D., Cho L.C., Papiez L., and Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25 (2007) 947-952
2. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
3. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
4. Wulf J., Baier K., Mueller G., and Flentje M.P. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
5. Chang J.Y., Balter P., Dong L., et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 72 (2008) 967-971
6. Norihisa Y., Nagata Y., Takayama K., et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 72 (2008) 398-403
7. Guckenberger M, Wulf J, Mueller G, et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4d dose calculation. Int J Radiat Oncol Biol Phys 2008.
8. Onimaru R., Fujino M., Yamazaki K., et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 374-381
9. McCammon R., Schefter T.E., Gaspar L.E., Zaemisch R., Gravdahl D., and Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol 73 (2009) 112-118
10. Joyner M., Salter B.J., Papanikolaou N., and Fuss M. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45 (2006) 802-807
11. Lagerwaard F.J., Haasbeek C.J., Smit E.F., Slotman B.J., and Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 685-692
12. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
13. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
14. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
15. Chen Y., Milano M.T., Roloff G., Smudzin T., and Okunieff P. Novalis stereotactic body radiotherapy for recurrent and newly diagnosed poor risk non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 72 (2008) S466-S467
16. Milano M.T., Katz A.W., Muhs A.G., et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112 (2008) 650-658
17. Milano M.T., Katz A.W., Schell M.C., Philip A., and Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative intent stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 72 (2008) 1516-1522
18. Okunieff P., Petersen A.L., Philip A., et al. Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol 45 (2006) 808-817
19. O'Dell W.G., Schell M.C., Reynolds D., and Okunieff P. Dose broadening due to target position variability during fractionated breath-held radiation therapy. Med Phys 29 (2002) 1430-1437
20. Milano M.T., Constine L.S., and Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 3 (2008) 36
21. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
22. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
23. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 (2006) 100-106
24. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 (2006) 787-795
25. Hof H., Muenter M., Oetzel D., Hoess A., Debus J., and Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110 (2007) 148-155
26. Brown J.M., and Koong A.C. High-dose single-fraction radiotherapy: exploiting a new biology?. Int J Radiat Oncol Biol Phys 71 (2008) 324-325
27. Park C., Papiez L., Zhang S., Story M., and Timmerman R.D. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 847-852
28. Senan S., Haasbeek N.J., Smit E.F., and Lagerwaard F.J. Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 25 (2007) 464 [author reply 465]
29. Le Q.T., Loo B.W., Ho A., et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 1 (2006) 802-809
30. Kopek N., Paludan M., Petersen J., Grau C., and Høyer M. Stereotactic body radiotherapy for medically inoperable stage I non-small cell lung cancer: Mature outcome and toxicity results. Int J Radiat Oncol Biol Phys 72 (2008) S37
31. Patel A.H., Ajlouni M., Jin J., Lu M., Ryu S., and Movsas B. Is stereotactic body radiotherapy (SBRT) safe for central non-small cell lung cancer (NSCLC) lesions?. Int J Radiat Oncol Biol Phys 72 (2008) S434-S435
32. Song D.Y., Benedict S.H., Cardinale R.M., Chung T.D., Chang M.G., and Schmidt-Ullrich R.K. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 28 (2005) 591-596
33. Song S., Choi W., Shin S., et al. Fractionated stereotactic body radiation therapy for central or peripheral stage I non-small cell lung cancer on consecutive days. Int J Radiat Oncol Biol Phys 72 (2008) S466
34. Rao S.S., Stroud J.S., Drzymala R.E., and Bradley J.D. Phase I trial of SBRT dose escalation for patients with inoperable stage I NSCLC arising within the zone of the proximal bronchial tree. Int J Radiat Oncol Biol Phys 72 (2008) S429-S430